DV
Dividend Vision

ENSC — Ensysce Biosciences Inc

Ensysce Biosciences Inc (ENSC)

Total return is -100.0% over the past 8.5 years, 318.2 points behind SPY at 218.2%. Its deepest 1-year drawdown was 90.2%.

Based on the data provided, this appears to be a single equity holding rather than a traditional ETF. Ensysce Biosciences is a biopharmaceutical company focused on drug delivery technologies, trading as an individual stock. With no stated distribution rate, expense ratio, or asset under management figures, it does not function as a diversified fund and lacks the typical characteristics of a dividend-focused ETF, making it unsuitable for income investors seeking regular distributions.

ENSC key facts

Asset type
Stock
Asset class
Equity
Inception date
02/26/2018
Last close
$0.40
Market cap
$4,345,371
Average volume
18577000.0
Beta
0.793
Payout ratio
0.0
Forward P/E
0.9496
EPS
$-3.11